The mid-point of 2026 has solidified a new competitive hierarchy within the drug delivery sector, as detailed in the Pen Injector Market Top Companies profiles. Market leaders such as Novo Nordisk, Eli Lilly, and Sanofi continue to hold a massive collective share, largely due to their "blockbuster" portfolios in the diabetes and obesity segments. However, the landscape is becoming increasingly...